Bridgeway Capital Management, LLC Hookipa Pharma Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.71 - $1.97 $63,971 - $177,497	-90,100 Reduced 50.73%	87,500 $77,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.03 $16,704 - $23,896	-23,200 Reduced 11.55%	177,600 $131,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $156,845 - $1.85 Million	123,500 Added 159.77%	200,800 $269,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $55,195 - $95,865	-41,500 Reduced 34.93%	77,300 $126,000
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $25,200 - $50,400	20,000 Added 20.24%	118,800 $271,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $68,502 - $174,636	-29,400 Reduced 22.93%	98,800 $230,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $755,098 - $1.2 Million	128,200 New	128,200 $755,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $155M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.